Go Pro
→ Trump's New Dollar (From Porter & Company) (Ad)tc pixel

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Compare
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
DaVita Inc. stock logo
DVA
DaVita
$183.08
-0.4%		$196.58
$101.00
▼
$247.49
$11.72B0.83682,389 shs544,272 shs
Fresenius Medical Care AG & Co. KGaA stock logo
FMS
Fresenius Medical Care AG & Co. KGaA
$22.44
-0.3%		$23.55
$20.02
▼
$27.64
$12.09B0.76634,358 shs735,433 shs
RadNet, Inc. stock logo
RDNT
RadNet
$73.21
-1.0%		$71.46
$50.82
▼
$85.84
$5.82B1.41750,352 shs560,678 shs
Tempus AI, Inc. stock logo
TEM
Tempus AI
$76.59
-0.8%		$58.39
$40.77
▼
$104.32
$13.93B3.726.44 million shs5.37 million shs
7 Stocks to Buy Before the Robotics Revolution Cover
7 Stocks to Buy Before the Robotics Revolution

Robotics and automation are rapidly becoming essential infrastructure across healthcare, manufacturing, logistics, and many other industries. "Physical AI" is coming. Learn which seven companies are most positioned to benefit as intelligent robots enter the workforce.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
DaVita Inc. stock logo
DVA
DaVita
+0.37%-4.06%+5.24%-14.04%+39.73%
Fresenius Medical Care AG & Co. KGaA stock logo
FMS
Fresenius Medical Care AG & Co. KGaA
+1.25%-1.94%-3.85%-5.60%-12.18%
RadNet, Inc. stock logo
RDNT
RadNet
+1.73%-4.14%-3.76%+27.11%-2.26%
Tempus AI, Inc. stock logo
TEM
Tempus AI
-1.08%+12.11%+6.19%+48.61%-10.11%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
DaVita Inc. stock logo
DVA
DaVita
$183.08
-0.4%		$196.58
$101.00
▼
$247.49
$11.72B0.83682,389 shs544,272 shs
Fresenius Medical Care AG & Co. KGaA stock logo
FMS
Fresenius Medical Care AG & Co. KGaA
$22.44
-0.3%		$23.55
$20.02
▼
$27.64
$12.09B0.76634,358 shs735,433 shs
RadNet, Inc. stock logo
RDNT
RadNet
$73.21
-1.0%		$71.46
$50.82
▼
$85.84
$5.82B1.41750,352 shs560,678 shs
Tempus AI, Inc. stock logo
TEM
Tempus AI
$76.59
-0.8%		$58.39
$40.77
▼
$104.32
$13.93B3.726.44 million shs5.37 million shs
7 Stocks to Buy Before the Robotics Revolution Cover
7 Stocks to Buy Before the Robotics Revolution

Robotics and automation are rapidly becoming essential infrastructure across healthcare, manufacturing, logistics, and many other industries. "Physical AI" is coming. Learn which seven companies are most positioned to benefit as intelligent robots enter the workforce.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
DaVita Inc. stock logo
DVA
DaVita
+0.37%-4.06%+5.24%-14.04%+39.73%
Fresenius Medical Care AG & Co. KGaA stock logo
FMS
Fresenius Medical Care AG & Co. KGaA
+1.25%-1.94%-3.85%-5.60%-12.18%
RadNet, Inc. stock logo
RDNT
RadNet
+1.73%-4.14%-3.76%+27.11%-2.26%
Tempus AI, Inc. stock logo
TEM
Tempus AI
-1.08%+12.11%+6.19%+48.61%-10.11%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
DaVita Inc. stock logo
DVA
DaVita
2.57
Moderate Buy$233.4327.50% Upside
Fresenius Medical Care AG & Co. KGaA stock logo
FMS
Fresenius Medical Care AG & Co. KGaA
1.55
Reduce$23.575.04% Upside
RadNet, Inc. stock logo
RDNT
RadNet
2.89
Moderate Buy$90.0022.93% Upside
Tempus AI, Inc. stock logo
TEM
Tempus AI
2.41
Hold$69.63-9.09% Downside

Current Analyst Ratings Breakdown

Latest RDNT, TEM, FMS, and DVA Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
9/22/2026
RadNet, Inc. stock logo
RDNT
RadNet
Raymond James Financial, Inc. logo
Raymond James Financial
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingStrong-Buy
9/21/2026
Tempus AI, Inc. stock logo
TEM
Tempus AI
The Goldman Sachs Group, Inc. logo
The Goldman Sachs Group
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Initiated CoverageNeutral$75.00
9/21/2026
Tempus AI, Inc. stock logo
TEM
Tempus AI
The Goldman Sachs Group, Inc. logo
The Goldman Sachs Group
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Initiated CoverageNeutral$75.00
9/11/2026
Tempus AI, Inc. stock logo
TEM
Tempus AI
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
UpgradeSell (E+) ➝ Sell (D-)
9/11/2026
Tempus AI, Inc. stock logo
TEM
Tempus AI
HC Wainwright logo
HC Wainwright
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetBuy$56.00 ➝ $66.00
9/9/2026
Tempus AI, Inc. stock logo
TEM
Tempus AI
UBS Group AG logo
UBS Group
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Initiated CoverageNeutral$70.00
9/8/2026
Tempus AI, Inc. stock logo
TEM
Tempus AI
Rothschild & Co Redburn logo
Rothschild & Co Redburn
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Initiated CoverageNeutral$67.00
9/8/2026
Tempus AI, Inc. stock logo
TEM
Tempus AI
Rothschild & Co Redburn logo
Rothschild & Co Redburn
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Initiated CoverageNeutral$67.00
9/8/2026
Tempus AI, Inc. stock logo
TEM
Tempus AI
Roth Capital logo
Roth Capital
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Initiated CoverageNeutral$67.00
9/2/2026
Tempus AI, Inc. stock logo
TEM
Tempus AI
Raymond James Financial, Inc. logo
Raymond James Financial
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Set Price Target$80.00
9/2/2026
Tempus AI, Inc. stock logo
TEM
Tempus AI
Cantor Fitzgerald logo
Cantor Fitzgerald
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Initiated CoverageOverweight$80.00
(Data available from 9/23/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
DaVita Inc. stock logo
DVA
DaVita
$13.64B0.86$21.79 per share8.40($5.29) per share-34.61
Fresenius Medical Care AG & Co. KGaA stock logo
FMS
Fresenius Medical Care AG & Co. KGaA
$19.43B0.62$5.62 per share3.99$28.93 per share0.78
RadNet, Inc. stock logo
RDNT
RadNet
$2.04B2.82$3.25 per share22.54$17.58 per share4.16
Tempus AI, Inc. stock logo
TEM
Tempus AI
$1.27B10.87N/AN/A$2.76 per share27.75
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
DaVita Inc. stock logo
DVA
DaVita
$746.80M$12.2214.9810.610.476.05%-217.63%5.07%10/28/2026 (Estimated)
Fresenius Medical Care AG & Co. KGaA stock logo
FMS
Fresenius Medical Care AG & Co. KGaA
$1.11B$1.9311.629.554.124.83%9.28%4.16%11/3/2026 (Estimated)
RadNet, Inc. stock logo
RDNT
RadNet
-$18.65M-$0.27N/A84.15N/A-0.93%2.61%0.91%11/9/2026 (Estimated)
Tempus AI, Inc. stock logo
TEM
Tempus AI
-$245.03M-$1.44N/AN/AN/A-17.77%-50.28%-10.33%11/3/2026 (Estimated)

Latest RDNT, TEM, FMS, and DVA Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/10/2026Q2 2026
RadNet, Inc. stock logo
RDNT
RadNet
$0.2014$0.29+$0.0886$0.10$610.87 million$622.72 million
8/4/2026Q2 2026
DaVita Inc. stock logo
DVA
DaVita
$3.88$4.02+$0.14$4.02$3.50 billion$3.55 billion
8/3/2026Q2 2026
Fresenius Medical Care AG & Co. KGaA stock logo
FMS
Fresenius Medical Care AG & Co. KGaA
$0.6160$0.66+$0.0440$0.46$5.48 billion$5.55 billion
7/30/2026Q2 2026
Tempus AI, Inc. stock logo
TEM
Tempus AI
-$0.1428-$0.04+$0.1028$0.03$379.69 million$382.49 million
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
DaVita Inc. stock logo
DVA
DaVita
N/AN/AN/AN/AN/A
Fresenius Medical Care AG & Co. KGaA stock logo
FMS
Fresenius Medical Care AG & Co. KGaA
$0.612.71%+2.66%31.61%N/A
RadNet, Inc. stock logo
RDNT
RadNet
N/AN/AN/AN/AN/A
Tempus AI, Inc. stock logo
TEM
Tempus AI
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
DaVita Inc. stock logo
DVA
DaVita
N/A
1.47
1.41
Fresenius Medical Care AG & Co. KGaA stock logo
FMS
Fresenius Medical Care AG & Co. KGaA
0.43
1.07
0.75
RadNet, Inc. stock logo
RDNT
RadNet
0.94
1.48
1.48
Tempus AI, Inc. stock logo
TEM
Tempus AI
3.06
3.30
3.16

Institutional Ownership

CompanyInstitutional Ownership
DaVita Inc. stock logo
DVA
DaVita
90.12%
Fresenius Medical Care AG & Co. KGaA stock logo
FMS
Fresenius Medical Care AG & Co. KGaA
8.37%
RadNet, Inc. stock logo
RDNT
RadNet
77.90%
Tempus AI, Inc. stock logo
TEM
Tempus AI
24.22%

Insider Ownership

CompanyInsider Ownership
DaVita Inc. stock logo
DVA
DaVita
1.90%
Fresenius Medical Care AG & Co. KGaA stock logo
FMS
Fresenius Medical Care AG & Co. KGaA
N/A
RadNet, Inc. stock logo
RDNT
RadNet
5.14%
Tempus AI, Inc. stock logo
TEM
Tempus AI
24.26%
CompanyEmployeesShares OutstandingFree FloatOptionable
DaVita Inc. stock logo
DVA
DaVita
78,00063.80 million62.59 millionOptionable
Fresenius Medical Care AG & Co. KGaA stock logo
FMS
Fresenius Medical Care AG & Co. KGaA
1,488537.13 millionN/AOptionable
RadNet, Inc. stock logo
RDNT
RadNet
11,26478.70 million74.65 millionOptionable
Tempus AI, Inc. stock logo
TEM
Tempus AI
3,800180.43 million136.66 millionN/A

Recent News About These Companies

Tempus AI (TEM) Has a $75 Goldman Sachs Target, But Its Data Business Faces a Bigger Test
September 22 at 5:31 PM  |  insidermonkey.comhttps://www.insidermonkey.com/news/tempus-ai-tem-has-a-75-goldman-sachs-target-but-its-data-business-faces-a-bigger-test-1841526/
3 Analysts, 3 Trades to Make Today
September 22 at 5:00 PM  |  investorplace.comhttps://investorplace.com/2026/09/3-analysts-3-trades-to-make-today/
Tempus AI: High Risk, But With A Great Cause
September 22 at 8:00 AM  |  seekingalpha.comhttps://seekingalpha.com/article/4948568-tempus-ai-high-risk-but-with-a-great-cause
Tempus AI (NASDAQ:TEM) Rating Increased to Hold at The Goldman Sachs Group
September 22 at 7:36 AM  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=31039710
Tempus AI (NASDAQ:TEM) Upgraded by The Goldman Sachs Group to Hold Rating
September 22 at 7:29 AM  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/analyst-tempus-ai-nasdaq-tem-upgraded-by-the-goldman-sachs-group-to-hold-rating-2026-09-22/
Tempus AI: Data And Applications Will Unlock More Upside
September 21 at 12:00 AM  |  seekingalpha.comhttps://seekingalpha.com/article/4948478-tempus-ai-stock-data-applications-will-unlock-more-upside
Tempus AI, Recursion Extend Data License, Amend Fee Structure
September 21 at 11:33 PM  |  finance.yahoo.comhttps://finance.yahoo.com/healthcare/articles/tempus-ai-recursion-extend-data-143658573.html
Tempus AI Sees Pricing, Data Growth Fueling Long-Term Expansion
September 21 at 8:01 PM  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/event-tempus-ai-sees-pricing-data-growth-fueling-long-term-expansion-2026-09-21/
Goldman Sachs Initiates Tempus AI at Neutral With $75 Price Target
September 21 at 6:32 PM  |  marketscreener.comM
Artificial Intelligence Stocks To Watch Now - September 21st
September 21 at 12:01 PM  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/list-artificial-intelligence-stocks-to-watch-now-september-21st-2026-09-21/
Tempus AI: Market Is Hyping On An Uncertain Number
September 21 at 9:37 AM  |  seekingalpha.comhttps://seekingalpha.com/article/4948316-tempus-ai-market-is-hyping-on-an-uncertain-number
Insider Selling: Tempus AI (NASDAQ:TEM) EVP Sells $221,325.00 in Stock
September 21 at 4:54 AM  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=31036577
Insider Selling: Tempus AI (NASDAQ:TEM) CAO Sells $529,650.00 in Stock
September 21 at 4:54 AM  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=31036572
Insider Selling: Tempus AI (NASDAQ:TEM) CEO Sells $16,114,000.00 in Stock
September 21 at 4:09 AM  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=31036306
Best Artificial Intelligence Stocks To Watch Now - September 18th
September 21 at 3:02 AM  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=31035753
Tempus AI (TEM) Is Building a Heart Failure Agent That Never Sleeps
September 21 at 2:11 AM  |  insidermonkey.comhttps://www.insidermonkey.com/news/tempus-ai-tem-is-building-a-heart-failure-agent-that-never-sleeps-1840781/
Tempus Secures Up To $9.5 Million From ARPA-H To Develop Autonomous AI Agent For Heart Failure Care
September 20 at 5:04 PM  |  pulse2.comP
Ryan Fukushima Sells 700 Shares of Tempus AI (NASDAQ:TEM) Stock
September 20 at 10:00 AM  |  defenseworld.netD
Tempus AI (TEM), What Is Behind The Latest Buzz?
September 20 at 7:03 AM  |  finance.yahoo.comhttps://finance.yahoo.com/markets/stocks/articles/tempus-ai-tem-behind-latest-051247679.html
Tempus AI (TEM) Is Up 31.9% After Launching 100,000‑Genome AI Research Platform Initiative
September 19, 2026  |  uk.finance.yahoo.comhttps://uk.finance.yahoo.com/news/tempus-ai-tem-31-9-161226574.html
Tempus AI (TEM) Unveils Whole Genome Platform With Plans For 1 Million Genomes
September 19, 2026  |  finance.yahoo.comhttps://finance.yahoo.com/healthcare/articles/tempus-ai-tem-unveils-whole-111421978.html

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Close-up of a carbon fiber surface bearing the AV logo and a camera sensor.
AeroVironment’s $465 Million Army Laser Win Expands Its Counter-Drone Opportunity
By Ryan Hasson | September 3, 2026
Autonomous military drone with AV-style logo on the nose sitting on a runway, representing AeroVironment and the defense drone industry.
AeroVironment's Record Backlog and Earnings Beat Fuel Recovery Case
By Thomas Hughes | September 10, 2026
Foldable Apple smartphone displayed on a table with a lit Apple logo and city skyline in the background.
Apple’s Foldable iPhone Could Be a Catalyst, But Not a Cure-All
By Sam Quirke | August 30, 2026
NVIDIA logo displayed on a wall inside a data center with server racks and monitors visible.
NVIDIA’s Hugging Face Deal Raises a Bigger Question About Its AI Moat Now
By Jeffrey Neal Johnson | September 3, 2026
Illustration of an upward-trending stock chart line overlaid on a city skyline of office towers at sunset.
Strike a Balance Between Growth and Stability With These 3 Names Ready to Rally
By Nathan Reiff | August 30, 2026
DaVita stock logo

DaVita NYSE:DVA

$183.08 -0.65 (-0.35%)
Closing price 03:59 PM Eastern
Extended Trading
$183.14 +0.06 (+0.03%)
As of 07:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers. In addition, the company offers integrated care and disease management services to patients in risk-based and other integrated care arrangements; clinical research programs; physician services; and comprehensive kidney care services. Further, it engages in the provision of acute inpatient dialysis services and related laboratory services; and transplant software business. The company was formerly known as DaVita HealthCare Partners Inc. and changed its name to DaVita Inc. in September 2016. DaVita Inc. was incorporated in 1994 and is headquartered in Denver, Colorado.

Fresenius Medical Care AG & Co. KGaA stock logo

Fresenius Medical Care AG & Co. KGaA NYSE:FMS

$22.44 -0.07 (-0.29%)
Closing price 03:59 PM Eastern
Extended Trading
$22.42 -0.01 (-0.07%)
As of 07:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Fresenius Medical Care AG provides dialysis and related services for individuals with renal diseases in Germany, North America, and internationally. The company offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure. It also develops, manufactures, and distributes various health care products, including polysulfone dialyzers, hemodialysis machines, peritoneal dialysis cyclers, peritoneal dialysis solutions, hemodialysis concentrates, solutions and granulates, bloodlines, renal pharmaceuticals, systems for water treatment, and acute cardiopulmonary and apheresis products. In addition, the company develops, acquires, and in-licenses renal pharmaceuticals; offers renal medications and supplies to patients at homes or to dialysis clinics; and provides vascular, cardiovascular, endovascular specialty, vascular care ambulatory surgery center, and physician nephrology and cardiology services. The company sells its products to dialysis clinics, hospitals, and specialized treatment clinics directly, as well as through local sales forces, independent distributors, dealers, and sales agents. Fresenius Medical Care AG was incorporated in 1996 and is headquartered in Bad Homburg, Germany.

RadNet stock logo

RadNet NASDAQ:RDNT

$73.21 -0.72 (-0.97%)
Closing price 04:00 PM Eastern
Extended Trading
$73.18 -0.03 (-0.05%)
As of 07:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

RadNet, Inc., together with its subsidiaries, provides outpatient diagnostic imaging services in the United States. The company operates in two segments: Imaging Centers and Artificial Intelligence. Its services include magnetic resonance imaging, computed tomography, positron emission tomography, nuclear medicine, mammography, ultrasound, diagnostic radiology, fluoroscopy, and other related procedures, as well as multi-modality imaging services. The company also develops and sells computerized systems that distribute, display, store, and retrieve digital images; offers picture archiving communications systems and related services; and develops and deploys AI suites to enhance radiologist interpretation of breast, lung, and prostate images, as well as AI solutions for prostate cancer screening. RadNet, Inc. was founded in 1981 and is headquartered in Los Angeles, California.

Tempus AI stock logo

Tempus AI NASDAQ:TEM

$76.59 -0.60 (-0.78%)
Closing price 04:00 PM Eastern
Extended Trading
$76.22 -0.37 (-0.48%)
As of 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Tempus AI Inc. is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics. Tempus AI Inc. is based in CHICAGO.

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

Stock Lists
Low Priced Stocks
Stocks By Exchange
Latest Stock Ideas